Search for: "Marks v. Philadelphia Wholesale Drug Company"
Results 1 - 5
of 5
Sorted by Relevance
|
Sort by Date
29 Aug 2016, 1:19 pm
Despite the drugs not being sanctioned for use in these areas, as well as not being adequately tested by the company before their release, Johnson & Johnson encountered very little friction from its decision to market the drug to patients for these unapproved uses. [read post]
23 May 2008, 1:03 am
: (Patent Baristas), Canada: Generic drug manufacturers urge Parliament to forfeit idea of new regulations delaying their ability to reproduce drugs: (Spicy IP), India: Indian generics and health activists having problem over patent titles: (Patent Circle), Europe: EPO to determine in June the fate of WARF stem cell patent application: (IPBiz), India: Choking the patients??? [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in… [read post]
20 Jun 2008, 8:07 am
– Comments on IPEG post on Zyprexa patent case: (BLOG@IP::JUR) India takes open source approach to drug discovery: (Patent Lens), India: Is the Indian Drug Controller participating in the ACTA negotiations? [read post]
1 Sep 2015, 6:07 am
But in the absence of wholesale opt outs, accommodation puts off the underlying issue for another day. [read post]
